Critics accuse the maker of Humira of exploiting patent laws to keep competitors’ less expensive versions off the market. The company, AbbVie, says it’s balancing the need to keep the drug affordable to patients with the need to fund new drug development
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Even the best stock-market investors fail when it’s time to sellEven the best stock-market investors fail when it’s time to sell (via MktwHulbert)
Weiterlesen »
As medical costs mount, Japan to weigh cost-effectiveness in setting drug pricesJapanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an ...
Weiterlesen »
I drove the world's best-selling electric car for a weekend — and I realized why electric cars need more than 200 miles of rangeI drove the 2018 Nissan Leaf for a weekend in December.
Weiterlesen »